about
Paritaprevir/ritonavir-ombitasvir and dasabuvir, the 3D regimen for the treatment of chronic hepatitis C virus infection: a concise reviewTherapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspectiveSuccessful Treatment of Hepatitis C with Simeprevir, Sofosbuvir, and Ribavirin in an HIV Coinfected Liver Transplant Patient with Advanced Chronic Kidney Disease.Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review.Therapeutic drug monitoring of voriconazole and posaconazole.Drug Interactions With Direct-Acting Antivirals for Hepatitis C: Implications for HIV and Transplant Patients.A review of direct-acting antivirals for the treatment of hepatitis C in patients with advanced chronic kidney disease.Concordance of sustained virologic response at weeks 4, 12 and 24 post-treatment of hepatitis c in the era of new oral direct-acting antivirals: A concise review.Transplanting Kidney Allografts from Hepatitis C Infected Donors into Hepatitis C Uninfected Recipients: Re-Thinking the Thinker Trial.Interaction of Gender and Hepatitis C in Risk of Chronic Renal Failure After Liver Transplantation.Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" Experience.First confirmed case of native polyomavirus BK nephropathy in a liver transplant recipient seven years post-transplant.Antimitochondrial antibody serocoversion post-liver transplant during hepatitis C treatment with peginterferon α, ribavirin and telaprevir.Editorial: hepatitis C direct acting anti-viral agents and the kidney.Liver Transplant Can Resolve Severe Neuropsychiatric Manifestations of Wilson Disease: A Case Report.Editorial: hepatocellular carcinoma as a consequence of hepatitis C direct-acting anti-virals-the great urban myth of hepatologyImmunosuppression Practices in Liver Transplantation: A Survey of North American CentersResponse to Sildenafil in a Patient With Coexisting Post-Liver Transplant Portopulmonary Hypertension and Hepatopulmonary Syndrome
P50
Q26747705-BBC285C8-3FA4-40DE-9043-398163101569Q27009221-1DCB25E8-8206-4019-8290-DC29DE16248BQ36996791-627F1122-D207-4784-9EF6-E08415DC0D9DQ37358534-593E0A86-183A-4BF7-ADB1-8C5DF6B3B162Q37833074-6A9D45AF-893F-4659-8645-F1A325C6E30AQ38377264-C95D18ED-D3E7-4EAE-9C6E-0A55AFE6AFB7Q38611155-C8240681-3973-45F8-80B0-C81476CD0DD0Q38723155-A86472A8-82B8-4C4F-A31A-6FBC89BC1C40Q40092793-9F6AE91A-BA97-4B3F-92A9-EC6A369203C3Q40319270-BC38BD2B-611D-49D5-913D-89F8DEEB71B3Q40764902-ADD96770-F8D9-42C2-8064-B1A536DE7ADBQ41584124-CF0BF30F-AE03-4553-A400-3320081546AEQ42198187-9925C85D-EC8E-4E86-B8EA-BF70C044A25BQ47720445-9E0408D2-5A93-4ED9-9E65-B835CED09B09Q50241049-6813FB22-0883-4785-AC94-37027C0F2B7FQ88418444-5FCA3F72-2191-4375-9645-B4F922B39383Q88861213-8D7FE937-CA44-42D3-AC39-1231548429E1Q89033846-B0BC8AB6-DF10-4B01-88A9-7907E721D1F4
P50
description
researcher ORCID ID = 0000-0002-6463-6847
@en
wetenschapper
@nl
name
Trana Hussaini
@ast
Trana Hussaini
@en
Trana Hussaini
@es
Trana Hussaini
@nl
type
label
Trana Hussaini
@ast
Trana Hussaini
@en
Trana Hussaini
@es
Trana Hussaini
@nl
prefLabel
Trana Hussaini
@ast
Trana Hussaini
@en
Trana Hussaini
@es
Trana Hussaini
@nl
P31
P496
0000-0002-6463-6847